TUAN LE: Open Payments
NPI 1417210204 · GARDEN GROVE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,813 in 32 payments from 15 companies in 2025. Trend: 2023 $3,060 · 2024 $2,658 · 2025 $1,813
Food & beverage: $1,813
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $254 |
| GlaxoSmithKline, LLC. | 3 | $250 |
| Amgen Inc. | 12 | $196 |
| Madrigal Pharmaceuticals | 1 | $143 |
| Novo Nordisk Inc | 1 | $125 |
| Corcept Therapeutics | 1 | $125 |
| GENZYME CORPORATION | 1 | $125 |
| ABBVIE INC. | 1 | $124 |
| Lilly USA, LLC | 1 | $120 |
| Axsome Therapeutics, Inc. | 1 | $118 |
Products named: BREZTRI, REZDIFFRA, Ozempic, Korlym, DUPIXENT, CREON, AREXVY, NUCALA.
Industry payments across CA — which companies pay providers there.
